Condensed Statements of Shareholders' Deficiency (Unaudited) - USD ($)	3 Months Ended
	Apr. 30, 2021	Apr. 30, 2020
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)	1,233,853
Beginning balance	$ (835,505)	$ (745,020)
Net loss	$ (21,167)	(20,417)
Ending balance (in shares)	1,233,853
Ending balance	$ (856,672)	$ (765,437)
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)	1,233,853	1,233,853
Beginning balance	$ 1,233	$ 1,233
Ending balance (in shares)	1,233,853	1,233,853
Ending balance	$ 1,233	$ 1,233
Additional Paid-in Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	81,323	81,323
Ending balance	81,323	81,323
Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	(918,061)	(827,576)
Net loss	(21,167)	(20,417)
Ending balance	$ (939,228)	$ (847,993)